October 18, 2011
…as the patient’s health, drugs and instruments used, team communication, and the wisdom of the surgeon’s hand. To advance safety and innovation in today’s operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest…
July 14, 2015
Scientists have designed nanoparticles that release drugs in the presence of a class of proteins that enable cancers to metastasize. That is, they have engineered a drug delivery system so that the very enzymes that make cancers dangerous could instead guide their destruction.
December 7, 2018
David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.
January 9, 2012
The new UC San Diego-Roche Extending Innovation Network (EIN) program has been launched with selection of its first three research projects at the University of California, San Diego School of Medicine.
November 30, 2018
A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.
October 27, 2022
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
August 21, 2013
MIT Technology Review has named Liangfang Zhang, a professor of nanoengineering at the University of California, San Diego, among the top 35 young innovators of 2013. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the…
February 22, 2016
Researchers at University of California, San Diego School of Medicine have discovered that HIV infection of human immune cells triggers a massive increase in methylation, a chemical modification, to both human and viral RNA, aiding replication of the virus. The study, published February 22, 2016 in Nature Microbiology, identifies a…
April 30, 2018
By stretching the amount of time proteins can be simulated in their natural state of wiggling and gyrating, a team of researchers at Colorado State University— using supercomputers at the San Diego Supercomputer Center at UC San Diego and the Pittsburgh Supercomputing Center—has identified a critical protein structure that could…
March 7, 2014
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.
